TCL Archive Extent Of Risk Reduction From Ovary Removal Varies According To BRCA Mutation February 29, 2008
TCL Archive In Brief: President OK’s Mammography Standard Publication, CDC State Grants Increase January 7, 1994
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
TCL Archive Study Finds 4-20% Of Those With HTLV-3 Develop AIDs Within 32 Months Or Less August 2, 1985
